Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1
- 22 May 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 67 (2-3) , 347-356
- https://doi.org/10.1016/s0168-3659(00)00226-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Erratum: Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaquesNature Medicine, 1999
- Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeysNature Medicine, 1999
- Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasmaNature Medicine, 1999
- In vivo migration and function of transferred HIV-1-specific cytotoxic T cellsNature Medicine, 1999
- A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDSVaccine, 1998
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Recent Advances in Vaccine Adjuvants for Systemic and Mucosal AdministrationJournal of Pharmacy and Pharmacology, 1998
- Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1997
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticlesVaccine, 1993